STOCK TITAN
  1. Home
  2. News
  3. MOVE

Movano Inc - MOVE STOCK NEWS

Welcome to our dedicated news page for Movano (Ticker: MOVE), a resource for investors and traders seeking the latest updates and insights on Movano.

Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect Movano's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.

Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of Movano's position in the market.

News
Movano Health Announces Blood Pressure Partnership Forum Following Significant Response to Groundbreaking Accuracy Achievement
Rhea-AI Summary
Movano Health (Nasdaq: MOVE) to Showcase Blood Pressure Monitoring Technology at CES and JP Morgan Healthcare Conference
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-3.74%
Tags
partnership
-
News
Movano Health's Women-First Wearable, the Evie Ring, Receives 2024 CES Innovation Award
Rhea-AI Summary
Movano Health (Nasdaq: MOVE) announced that the Evie Ring, a smart ring designed for women's health, received a 2024 CES Innovation Honoree Award. The ring offers innovative features such as tracking menstrual cycles, sleep stages, and blood oxygen saturation, providing personalized insights to empower women with actionable health data. Movano Health also demonstrated breakthrough results in its blood pressure clinical trial and is making headway in non-invasive glucose monitoring.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.25%
Tags
none
-
News
Movano Health Announces Over $1M Black Friday Holiday Launch Results for the Evie Ring as well as Cuffless Blood Pressure Milestone Achievement
Rhea-AI Summary
Movano Health (Nasdaq: MOVE) announces successful ecommerce launch of the Evie Ring, driving over $1 million in orders through the Thanksgiving Holiday. The company is also spearheading innovation in blood pressure measurement technology, recently attaining accurate cuffless and continuous blood pressure monitoring. Additionally, Movano Health is making significant progress in non-invasive glucose monitoring.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
4.07%
Tags
none
News
Evie, the Smart Ring for Women from Movano Health, Available for Order Today
Rhea-AI Summary
Movano Health (Nasdaq: MOVE) introduces the Evie Ring, a smart ring designed for women, offering innovative design, women-focused metrics, and cross-data trend analysis. Orders start at 12 pm EST, providing a valuable tool for women's health and fitness tracking.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
2.35%
Tags
none
-
News
Movano Health Announces Closing of $4.1 Million Public Offering Including Full Exercise of Over-Allotment Option
Rhea-AI Summary
Movano Health (Nasdaq: MOVE) announced the closing of its $4.1 million underwritten public offering of 4,870,600 shares of its common stock, including the full exercise of the underwriter's over-allotment option. The public offering price was $0.85 per share. The net proceeds will be used for general corporate purposes, including funding product development and commercialization activities. The Benchmark Company, LLC acted as sole book-running manager for the offering, and K&L Gates LLP represented the Company in the transaction.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.7%
Tags
offering
-
News
Movano Health Provides Business Update and Reports Third Quarter 2023 Financial Results
Rhea-AI Summary
Movano Health (Nasdaq: MOVE) reported financial results for the third quarter of 2023, including the launch of its first product, the Evie Ring, and updates on clinical studies and FDA submissions. The company also announced a public offering of its common stock and discussed its financial results.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-12.09%
Tags
earnings
News
Movano Health Prices $3.6 Million Public Offering
Rhea-AI Summary
Movano Health (Nasdaq: MOVE) Announces Pricing of $3.6 Million Public Offering of Common Stock. The purpose-driven healthcare solutions company is offering 4,235,304 shares of common stock at a price of $0.85 per share, with an option for the underwriter to purchase an additional 15%. The net proceeds will be used for general corporate purposes, including product development and commercialization activities.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-12.09%
Tags
offering
-
News
Movano Inc. to Report Third Quarter 2023 Financial Results on Wednesday, November 15, 2023
Rhea-AI Summary
Movano Inc. (NASDAQ: MOVE) Reschedules Q3 Results Conference Call to 11:30 am EST on November 15, 2023
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-12.09%
Tags
conferences earnings
-
News
Movano Health Announces Proposed Public Offering
Rhea-AI Summary
Movano Health (Nasdaq: MOVE) Announces Proposed Public Offering of Common Stock. Movano Health, a healthcare solutions company, is proposing to sell shares of its common stock in an underwritten public offering. The company intends to grant the underwriter a 30-day option to purchase up to an additional 15% of shares of common stock sold in the offering. The net proceeds from the offering will be used for general corporate purposes, including funding product development and commercialization activities.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-12.09%
Tags
offering
News
Movano Inc. to Report Third Quarter 2023 Financial Results Tuesday, November 14, 2023
Rhea-AI Summary
Movano Health, a healthcare solutions company, will report Q3 2023 financial results on November 14. A conference call and webcast will be held at 2:00 p.m. PST.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
conferences earnings
Stock MOVE logo
Movano Inc

Nasdaq:MOVE

MOVE Rankings

#4759 Ranked by Market Cap
#5022 Ranked by Stock Gains
N/A Ranked by Dividends

MOVE Stock Data

53.52M
25.98M
15.3%
12.87%
0.19%
Electromedical and Electrotherapeutic Apparatus Manufacturing
Manufacturing
Link
United States
Pleasanton

About MOVE

movano is a health-focused technology company that believes glucose is an important health metric to continuously track, as glucose levels serve as a proxy for metabolic health and risk for chronic disease, such as diabetes. we also believe that whether you are a person with diabetes, prediabetes or someone looking to pursue a healthier lifestyle, monitoring and managing your glucose levels shouldn’t be painful, complicated or conspicuous.